Name: Global Gene Therapy Drugs Market Insights, Forecast to 2035
Brand: Extent Research
Price: 3500 USD
Availability: InStock
Rating: 4.9 (222 reviews)

Global Gene Therapy Drugs Market

Market Size in USD Billion

CAGR : 17.60%

USD 1.14

2025

USD 4.17

2033

Forecast Period	2025 - 2033
Market Size (Base Year)	USD 1.14 Billion
Market Size (Forecast)	USD 4.17 Billion
CAGR	17.60%
Major Market Players	Data provided in full report

In the global Gene Therapy Drugs Market report published by Extent Research, the various market segments and growth drivers including challenges, threats, and opportunities have been well-discussed. In addition, the market research report provides the necessary assistance and guidance to various other research experts and companies to take the right decision. The hopes on making profitable decisions and funds from the Gene Therapy Drugs market is believed to be sky rocketing. The use of unbiased and intricate research has helped en route toward the escalating growth and supreme industry finances during the forecast period. The comprehensive report also clearly explains the growth influencers and market strategies to help propel the Gene Therapy Drugs market growth.

Data provided by Extent Research. Source: https://www.extentresearch.com/gene-therapy-drugs-market

The global Gene Therapy Drugs market is estimated to show an optimistic growth valuation over the forecast period. Additionally, the detailing about the key players F. Hoffmann-La Roche AG, Novartis International AG, Gilead Sciences, Inc., Ultragenyx Pharmaceutical，Inc., Applied Genetic Technologies Corp, Audentes Therapeutics, BioMarin Pharmaceutical, Bluebird Bio, Nightstar Therapeutics, Sangamo Therapeutics, Spark Therapeutics, uniQure, VBL Therapeutics, Voyager Therapeutics, also helps further understand the market status on the global and regional platform. However, the sudden and unpredictable onset of the global coronavirus pandemic has had a huge impact on the market growth. The real-time market research has shown the Gene Therapy Drugs market business to be affected by the globe pandemic. The report provides workable insights and necessary cues on the market potential on both the global and regional platform. From the demographic point of view, the regions North America, Europe, Asia Pacific, Latin America, Middle East & Africa, have the Gene Therapy Drugs industry leveraging growth through controlled practices.

Segmentation of the Global Gene Therapy Drugs Market:

By Product type

Neuromuscular Disease, Genetic Disease, Other,

by Application

Hospital, Pharmacy,

The report also covers all the historical, current, and future market trends and practices as well. Considering the market scenario, it is very necessary the market potential is reflected with a unique and holistic pattern such that the global Gene Therapy Drugs market analysis is crystal clear.

Why to invest in the report?

Detailed study on the Gene Therapy Drugs market dynamic segmentation
Complete investigation of the global Gene Therapy Drugs market
Universal review of the important market adaptations and developments
Realistic and flexible changes in the market statistics and growth
Holistic review of the market strategies adapted by the key players
Study on the market size and volume depending on the historical, present, and foreseeable growth projections
In-depth analysis of the existing competition on both the regional and global levels that will have a huge influence on the future business expansion

Report Scope and Market Segmentation

ATTRIBUTES	Global Gene Therapy Drugs Market KEY MARKET INSIGHTS
Segments Covered	By Product Type: All Products Type Includes By Application: All Application Type Includes By End User: All End User Type Includes By Distribution Channel: All Distribution Channel Includes
Countries Covered	North America U.S., Canada, Mexico Europe Germany, United Kingdom, France, Italy, Spain, Nordic Countries, Benelux Union, Rest of Europe Asia-Pacific China, India, Japan, New Zealand, South Korea, Australia, Southeast Asia, Rest of Asia Pacific Latin America Brazil, Argentina, Rest of Latin America Middle East & Africa Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa
Key Market Players	Leading Tier 1 Corporations Prominent Regional Manufacturers Emerging Market Disruptors Technology Integrators & Suppliers *Complete vendor layout of 15+ major players provided in the final report.
Market Opportunities	Market Size and Growth: Quantifying the total addressable market (TAM) and projected growth rates to assess financial viability. Customer Segmentation: Identifying target audience behaviors, pain points, and specific unfulfilled demands. Competitive Landscape: Analyzing existing competitors' strengths, weaknesses, and market share to pinpoint gaps and opportunities. Industry Trends: Mapping technological, regulatory, and economic shifts that create favorable conditions for market entry. Risk Assessment: Evaluating barriers to entry and operational challenges alongside strategic roadmaps for mitigation.
Value Added Data Infosets	In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by our expert team also include in-depth expert analysis, geographically represented company-wise production and capacity, network layouts of distributors and partners, detailed and updated price trend analysis and deficit analysis of supply chain and demand.

Meet the Team

Julie

Author

Julie Jayne is a distinguished multidisciplinary strategist and the Head of Research at Extent Research, where she leverages over a decade of comprehensive experience in the global market intelligence industry. Backed by a robust academic foundation that includes a B.Sc. and an MBA, she perfectly...

Priya M

Reviewed By

With over 14 years of dedicated professional expertise in business-to-business (B2B) intelligence, Priya M stands as a distinguished leader in corporate strategy, revenue growth, and advanced data analysis. Her dynamic career is defined by a relentless focus on mitigating business risks and empowering corporate executives...

Learn more about Priya M

BASIC ATTRIBUTES \| KEY MARKET INSIGHTS
Report Title	Global Gene Therapy Drugs Market
Base Year	2025
Forecast Period	2025 - 2033
Market Size (Base)	USD 1.14 Billion
Projected Size	USD 4.17 Billion
CAGR	17.60%

                            1 Report Business Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Gene Therapy Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2035
        1.2.2 Neuromuscular Disease
        1.2.3 Genetic Disease
        1.2.4 Other
    1.3 Market by Application
        1.3.1 Global Gene Therapy Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2035
        1.3.2 Hospital
        1.3.3 Pharmacy
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Gene Therapy Drugs Market Perspective (2017-2035)
    2.2 Gene Therapy Drugs Growth Trends by Region
        2.2.1 Gene Therapy Drugs Market Size by Region: 2017 VS 2021 VS 2035
        2.2.2 Gene Therapy Drugs Historic Market Size by Region (2017-2022)
        2.2.3 Gene Therapy Drugs Forecasted Market Size by Region (2023-2035)
    2.3 Gene Therapy Drugs Market Dynamics
        2.3.1 Gene Therapy Drugs Industry Trends
        2.3.2 Gene Therapy Drugs Market Drivers
        2.3.3 Gene Therapy Drugs Market Challenges
        2.3.4 Gene Therapy Drugs Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Gene Therapy Drugs Players by Revenue
        3.1.1 Global Top Gene Therapy Drugs Players by Revenue (2017-2022)
        3.1.2 Global Gene Therapy Drugs Revenue Market Share by Players (2017-2022)
    3.2 Global Gene Therapy Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Gene Therapy Drugs Revenue
    3.4 Global Gene Therapy Drugs Market Concentration Ratio
        3.4.1 Global Gene Therapy Drugs Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Gene Therapy Drugs Revenue in 2021
    3.5 Gene Therapy Drugs Key Players Head office and Area Served
    3.6 Key Players Gene Therapy Drugs Product Solution and Service
    3.7 Date of Enter into Gene Therapy Drugs Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Gene Therapy Drugs Breakdown Data by Type
    4.1 Global Gene Therapy Drugs Historic Market Size by Type (2017-2022)
    4.2 Global Gene Therapy Drugs Forecasted Market Size by Type (2023-2035)
5 Gene Therapy Drugs Breakdown Data by Application
    5.1 Global Gene Therapy Drugs Historic Market Size by Application (2017-2022)
    5.2 Global Gene Therapy Drugs Forecasted Market Size by Application (2023-2035)
6 North America
    6.1 North America Gene Therapy Drugs Market Size (2017-2035)
    6.2 North America Gene Therapy Drugs Market Size by Type
        6.2.1 North America Gene Therapy Drugs Market Size by Type (2017-2022)
        6.2.2 North America Gene Therapy Drugs Market Size by Type (2023-2035)
        6.2.3 North America Gene Therapy Drugs Market Share by Type (2017-2035)
    6.3 North America Gene Therapy Drugs Market Size by Application
        6.3.1 North America Gene Therapy Drugs Market Size by Application (2017-2022)
        6.3.2 North America Gene Therapy Drugs Market Size by Application (2023-2035)
        6.3.3 North America Gene Therapy Drugs Market Share by Application (2017-2035)
    6.4 North America Gene Therapy Drugs Market Size by Country
        6.4.1 North America Gene Therapy Drugs Market Size by Country (2017-2022)
        6.4.2 North America Gene Therapy Drugs Market Size by Country (2023-2035)
        6.4.3 United States
        6.4.4 Canada
7 Europe
    7.1 Europe Gene Therapy Drugs Market Size (2017-2035)
    7.2 Europe Gene Therapy Drugs Market Size by Type
        7.2.1 Europe Gene Therapy Drugs Market Size by Type (2017-2022)
        7.2.2 Europe Gene Therapy Drugs Market Size by Type (2023-2035)
        7.2.3 Europe Gene Therapy Drugs Market Share by Type (2017-2035)
    7.3 Europe Gene Therapy Drugs Market Size by Application
        7.3.1 Europe Gene Therapy Drugs Market Size by Application (2017-2022)
        7.3.2 Europe Gene Therapy Drugs Market Size by Application (2023-2035)
        7.3.3 Europe Gene Therapy Drugs Market Share by Application (2017-2035)
    7.4 Europe Gene Therapy Drugs Market Size by Country
        7.4.1 Europe Gene Therapy Drugs Market Size by Country (2017-2022)
        7.4.2 Europe Gene Therapy Drugs Market Size by Country (2023-2035)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Gene Therapy Drugs Market Size (2017-2035)
    8.2 Asia-Pacific Gene Therapy Drugs Market Size by Type
        8.2.1 Asia-Pacific Gene Therapy Drugs Market Size by Type (2017-2022)
        8.2.2 Asia-Pacific Gene Therapy Drugs Market Size by Type (2023-2035)
        8.2.3 Asia-Pacific Gene Therapy Drugs Market Share by Type (2017-2035)
    8.3 Asia-Pacific Gene Therapy Drugs Market Size by Application
        8.3.1 Asia-Pacific Gene Therapy Drugs Market Size by Application (2017-2022)
        8.3.2 Asia-Pacific Gene Therapy Drugs Market Size by Application (2023-2035)
        8.3.3 Asia-Pacific Gene Therapy Drugs Market Share by Application (2017-2035)
    8.4 Asia-Pacific Gene Therapy Drugs Market Size by Region
        8.4.1 Asia-Pacific Gene Therapy Drugs Market Size by Region (2017-2022)
        8.4.2 Asia-Pacific Gene Therapy Drugs Market Size by Region (2023-2035)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia 
9 Latin America
    9.1 Latin America Gene Therapy Drugs Market Size (2017-2035)
    9.2 Latin America Gene Therapy Drugs Market Size by Type
        9.2.1 Latin America Gene Therapy Drugs Market Size by Type (2017-2022)
        9.2.2 Latin America Gene Therapy Drugs Market Size by Type (2023-2035)
        9.2.3 Latin America Gene Therapy Drugs Market Share by Type (2017-2035)
    9.3 Latin America Gene Therapy Drugs Market Size by Application
        9.3.1 Latin America Gene Therapy Drugs Market Size by Application (2017-2022)
        9.3.2 Latin America Gene Therapy Drugs Market Size by Application (2023-2035)
        9.3.3 Latin America Gene Therapy Drugs Market Share by Application (2017-2035)
    9.4 Latin America Gene Therapy Drugs Market Size by Country
        9.4.1 Latin America Gene Therapy Drugs Market Size by Country (2017-2022)
        9.4.2 Latin America Gene Therapy Drugs Market Size by Country (2023-2035)
        9.4.3 Mexico
        9.4.4 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Gene Therapy Drugs Market Size (2017-2035)
    10.2 Middle East & Africa Gene Therapy Drugs Market Size by Type
        10.2.1 Middle East & Africa Gene Therapy Drugs Market Size by Type (2017-2022)
        10.2.2 Middle East & Africa Gene Therapy Drugs Market Size by Type (2023-2035)
        10.2.3 Middle East & Africa Gene Therapy Drugs Market Share by Type (2017-2035)
    10.3 Middle East & Africa Gene Therapy Drugs Market Size by Application
        10.3.1 Middle East & Africa Gene Therapy Drugs Market Size by Application (2017-2022)
        10.3.2 Middle East & Africa Gene Therapy Drugs Market Size by Application (2023-2035)
        10.3.3 Middle East & Africa Gene Therapy Drugs Market Share by Application (2017-2035)
    10.4 Middle East & Africa Gene Therapy Drugs Market Size by Country
        10.4.1 Middle East & Africa Gene Therapy Drugs Market Size by Country (2017-2022)
        10.4.2 Middle East & Africa Gene Therapy Drugs Market Size by Country (2023-2035)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE
11 Key Players Profiles
    11.1 F. Hoffmann-La Roche AG
        11.1.1 F. Hoffmann-La Roche AG Company Details
        11.1.2 F. Hoffmann-La Roche AG Business Overview
        11.1.3 F. Hoffmann-La Roche AG Gene Therapy Drugs Introduction
        11.1.4 F. Hoffmann-La Roche AG Revenue in Gene Therapy Drugs Business (2017-2022)
        11.1.5 F. Hoffmann-La Roche AG Recent Developments
    11.2 Novartis International AG
        11.2.1 Novartis International AG Company Details
        11.2.2 Novartis International AG Business Overview
        11.2.3 Novartis International AG Gene Therapy Drugs Introduction
        11.2.4 Novartis International AG Revenue in Gene Therapy Drugs Business (2017-2022)
        11.2.5 Novartis International AG Recent Developments
    11.3 Gilead Sciences, Inc.
        11.3.1 Gilead Sciences, Inc. Company Details
        11.3.2 Gilead Sciences, Inc. Business Overview
        11.3.3 Gilead Sciences, Inc. Gene Therapy Drugs Introduction
        11.3.4 Gilead Sciences, Inc. Revenue in Gene Therapy Drugs Business (2017-2022)
        11.3.5 Gilead Sciences, Inc. Recent Developments
    11.4 Ultragenyx Pharmaceutical，Inc.
        11.4.1 Ultragenyx Pharmaceutical，Inc. Company Details
        11.4.2 Ultragenyx Pharmaceutical，Inc. Business Overview
        11.4.3 Ultragenyx Pharmaceutical，Inc. Gene Therapy Drugs Introduction
        11.4.4 Ultragenyx Pharmaceutical，Inc. Revenue in Gene Therapy Drugs Business (2017-2022)
        11.4.5 Ultragenyx Pharmaceutical，Inc. Recent Developments
    11.5 Applied Genetic Technologies Corp
        11.5.1 Applied Genetic Technologies Corp Company Details
        11.5.2 Applied Genetic Technologies Corp Business Overview
        11.5.3 Applied Genetic Technologies Corp Gene Therapy Drugs Introduction
        11.5.4 Applied Genetic Technologies Corp Revenue in Gene Therapy Drugs Business (2017-2022)
        11.5.5 Applied Genetic Technologies Corp Recent Developments
    11.6 Audentes Therapeutics
        11.6.1 Audentes Therapeutics Company Details
        11.6.2 Audentes Therapeutics Business Overview
        11.6.3 Audentes Therapeutics Gene Therapy Drugs Introduction
        11.6.4 Audentes Therapeutics Revenue in Gene Therapy Drugs Business (2017-2022)
        11.6.5 Audentes Therapeutics Recent Developments
    11.7 BioMarin Pharmaceutical
        11.7.1 BioMarin Pharmaceutical Company Details
        11.7.2 BioMarin Pharmaceutical Business Overview
        11.7.3 BioMarin Pharmaceutical Gene Therapy Drugs Introduction
        11.7.4 BioMarin Pharmaceutical Revenue in Gene Therapy Drugs Business (2017-2022)
        11.7.5 BioMarin Pharmaceutical Recent Developments
    11.8 Bluebird Bio
        11.8.1 Bluebird Bio Company Details
        11.8.2 Bluebird Bio Business Overview
        11.8.3 Bluebird Bio Gene Therapy Drugs Introduction
        11.8.4 Bluebird Bio Revenue in Gene Therapy Drugs Business (2017-2022)
        11.8.5 Bluebird Bio Recent Developments
    11.9 Nightstar Therapeutics
        11.9.1 Nightstar Therapeutics Company Details
        11.9.2 Nightstar Therapeutics Business Overview
        11.9.3 Nightstar Therapeutics Gene Therapy Drugs Introduction
        11.9.4 Nightstar Therapeutics Revenue in Gene Therapy Drugs Business (2017-2022)
        11.9.5 Nightstar Therapeutics Recent Developments
    11.10 Sangamo Therapeutics
        11.10.1 Sangamo Therapeutics Company Details
        11.10.2 Sangamo Therapeutics Business Overview
        11.10.3 Sangamo Therapeutics Gene Therapy Drugs Introduction
        11.10.4 Sangamo Therapeutics Revenue in Gene Therapy Drugs Business (2017-2022)
        11.10.5 Sangamo Therapeutics Recent Developments
    11.11 Spark Therapeutics
        11.11.1 Spark Therapeutics Company Details
        11.11.2 Spark Therapeutics Business Overview
        11.11.3 Spark Therapeutics Gene Therapy Drugs Introduction
        11.11.4 Spark Therapeutics Revenue in Gene Therapy Drugs Business (2017-2022)
        11.11.5 Spark Therapeutics Recent Developments
    11.12 uniQure
        11.12.1 uniQure Company Details
        11.12.2 uniQure Business Overview
        11.12.3 uniQure Gene Therapy Drugs Introduction
        11.12.4 uniQure Revenue in Gene Therapy Drugs Business (2017-2022)
        11.12.5 uniQure Recent Developments
    11.13 VBL Therapeutics
        11.13.1 VBL Therapeutics Company Details
        11.13.2 VBL Therapeutics Business Overview
        11.13.3 VBL Therapeutics Gene Therapy Drugs Introduction
        11.13.4 VBL Therapeutics Revenue in Gene Therapy Drugs Business (2017-2022)
        11.13.5 VBL Therapeutics Recent Developments
    11.14 Voyager Therapeutics
        11.14.1 Voyager Therapeutics Company Details
        11.14.2 Voyager Therapeutics Business Overview
        11.14.3 Voyager Therapeutics Gene Therapy Drugs Introduction
        11.14.4 Voyager Therapeutics Revenue in Gene Therapy Drugs Business (2017-2022)
        11.14.5 Voyager Therapeutics Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Author Details
    13.3 Disclaimer                        

Research Methodology

Data collection and base year analysis are done using proprietary data collection modules with large sample sizes. The process includes obtaining market information through extensive secondary sources, paid databases, and verifying data via primary (industry expert) validation.

Our market models include Vendor Positioning Grids, Market Timeline Analysis, Company Market Share Analysis, and Top-Down/Bottom-Up forecasting models. To know more about the research methodology, drop an inquiry to speak to our industry experts.

Speak to Analyst

Global Gene Therapy Drugs Market